HC
Hara Capital Portfolio holdings
AUM
$161M
1-Year Return
2%
This Quarter Return
-2.41%
1 Year Return
-2%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$313M
AUM Growth
+$152M
(+94%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
50.12%
Top 10 Holdings %
Top 10 Hldgs %
34.58%
Holding
318
New
17
Increased
280
Reduced
14
Closed
6
Top Buys
| 1 |
PBF Energy
PBF
|
$15.7M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$6.46M |
| 3 |
Valaris
VAL
|
$5.81M |
| 4 |
Schlumberger
SLB
|
$5.62M |
| 5 |
Exxon Mobil
XOM
|
$4.53M |
Top Sells
Sector Composition
| 1 | Energy | 39.52% |
| 2 | Technology | 9.31% |
| 3 | Financials | 5.98% |
| 4 | Materials | 5.39% |
| 5 | Industrials | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SILV
276
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $8.19K | ﹤0.01% |
900
+250
| +38% | +$2.28K |
|
277
Fidelity National Information Services
FIS
$35.9B
| $7.92K | ﹤0.01% |
98
+49
| +100% | +$3.96K |
|
278
Accenture
ACN
$159B
| $7.74K | ﹤0.01% |
22
+11
| +100% | +$3.87K |
|
279
Endava
DAVA
$553M
| $7.73K | ﹤0.01% |
+250
| New | +$7.73K |
|
280
Franklin FTSE Japan ETF
FLJP
$2.34B
| $6.87K | ﹤0.01% |
240
+120
| +100% | +$3.43K |
|
281
Vertex Pharmaceuticals
VRTX
$102B
| $6.44K | ﹤0.01% |
16
+8
| +100% | +$3.22K |
|
|
TEI
282
Templeton Emerging Markets Income Fund
TEI
$294M
| $5.75K | ﹤0.01% |
1,120
-2,380
| -68% | -$12.2K |
|
283
Bunge Global
BG
$16.9B
| $5.44K | ﹤0.01% |
70
+35
| +100% | +$2.72K |
|
284
AstraZeneca
AZN
$253B
| $5.24K | ﹤0.01% |
80
+40
| +100% | +$2.62K |
|
285
Humana
HUM
$37B
| $5.07K | ﹤0.01% |
20
+10
| +100% | +$2.54K |
|
286
Equinox Gold
EQX
$7.65B
| $5.02K | ﹤0.01% |
1,000
+500
| +100% | +$2.51K |
|
287
Amplify Junior Silver Miners ETF
SILJ
$2.07B
| $4.83K | ﹤0.01% |
486
+243
| +100% | +$2.41K |
|
288
United Parcel Service
UPS
$72.1B
| $4.54K | ﹤0.01% |
36
+18
| +100% | +$2.27K |
|
289
Idexx Laboratories
IDXX
$51.4B
| $4.13K | ﹤0.01% |
10
+5
| +100% | +$2.07K |
|
290
Franklin Resources
BEN
$13B
| $4.06K | ﹤0.01% |
200
+100
| +100% | +$2.03K |
|
291
Veralto
VLTO
$26.2B
| $3.87K | ﹤0.01% |
38
+19
| +100% | +$1.94K |
|
292
Philip Morris
PM
$251B
| $3.61K | ﹤0.01% |
30
+15
| +100% | +$1.81K |
|
293
ZimVie
ZIMV
$532M
| $3.57K | ﹤0.01% |
256
+128
| +100% | +$1.79K |
|
|
SOBO
294
South Bow Corporation
SOBO
$5.76B
| $2.97K | ﹤0.01% |
+126
| New | +$2.97K |
|
295
Boston Scientific
BSX
$159B
| $2.86K | ﹤0.01% |
32
+16
| +100% | +$1.43K |
|
|
IIF
296
Morgan Stanley India Investment Fund
IIF
$254M
| $2.53K | ﹤0.01% |
100
+15
| +18% | +$379 |
|
297
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $2.34K | ﹤0.01% |
30
-40
| -57% | -$3.12K |
|
298
Colgate-Palmolive
CL
$68.8B
| $2K | ﹤0.01% |
22
+11
| +100% | +$1K |
|
299
IQVIA
IQV
$31.9B
| $1.97K | ﹤0.01% |
10
+5
| +100% | +$983 |
|
300
FMC
FMC
$4.72B
| $1.94K | ﹤0.01% |
40
-70
| -64% | -$3.4K |
|